SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

April 14, 2010 06:00 ET

BIOLASE Awarded New Laser Diode Patent

IRVINE, CA--(Marketwire - April 14, 2010) -  BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced that it was awarded a new patent (U.S. Patent number 7,695,469 B2), based on a patent application that was filed in 2007, for technology that is utilized in the groundbreaking ezlase™ and iLase™ diode lasers.

The patent, granted yesterday, contains 20 separate claims. The patent describes some of the technology found in the ezlase and also contains drawings of two additional battery-powered, stand-alone lasers that were under development at the time of filing. One of those lasers is completely wireless, and shows an earlier concept of what became the iLase. It illustrates the display, controls, laser and batteries, all included as part of a single cylindrical handpiece. The iLase of today incorporates the latest laser technologies and a unique patent-pending 360 degree control switch right on the handpiece, eliminating the need for a footswitch.

David M. Mulder, Chief Executive Officer of BIOLASE, stated, "We are very pleased to now have an issued patent covering some of the key technologies that were the conception of and resulted in the launch of iLase this year. This issued patent is illustrative of our robust intellectual property portfolio and our leadership position in lasers. We look forward to bringing forward more of those innovations to further enhance the world of dental and medical care."

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, develops, manufactures and markets Waterlase technology and lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with reduced pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology, pain management and other medical and consumer markets.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact: Jill Bertotti (investor) and Len Hall (media), of Allen & Caron, +1-949-474-4300.